These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3548959)

  • 21. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer.
    O'Connell MJ; Schutt AJ; Moertel CG; Hahn RG
    J Clin Oncol; 1987 Jan; 5(1):83-5. PubMed ID: 3100727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical decision in clinical oncology: the example of drug therapy of gastric cancer in the advanced stage during the last decade].
    Kenis Y
    Bull Cancer; 1987; 74(2):191-5. PubMed ID: 3607302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated hemolytic uremic syndrome.
    Hrozencik SP; Connaughton MJ
    Oncol Nurs Forum; 1988; 15(6):755-9. PubMed ID: 3205834
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adjuvant chemotherapy in advanced stomach cancer].
    Zehner J; Weber L; Fischer M; Gfirtner H; Breit A
    Med Klin (Munich); 1986 Jun; 81(13):445-8. PubMed ID: 3785030
    [No Abstract]   [Full Text] [Related]  

  • 26. [A five-year-survival case in which complete response was recognized after combined chemotherapy using 5-fluorouracil, adriamycin and mitomycin C (FAM) for unresectable gastric cancer].
    Iwase K; Takenaka H; Sumimura J; Ishizaka T; Takagaki M; Bessho T; Ohata T; Inoue M; Oshima S; Tanaka T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2235-7. PubMed ID: 1444491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy of stomach cancer].
    Gropp C; Havemann K
    Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
    Gupta S; Raina V; Jain P; Gujral S; Kumar R
    J Assoc Physicians India; 2000 Jun; 48(6):639-40. PubMed ID: 11273547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
    Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
    Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
    Gibson MK; Holcroft CA; Kvols LK; Haller D
    Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
    Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
    J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
    Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
    Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAM therapy for advanced gastric cancer: an ideal standard?
    Cullinan SA; Moertel CG
    J Clin Oncol; 1985 Jun; 3(6):887-9. PubMed ID: 3891923
    [No Abstract]   [Full Text] [Related]  

  • 34. The treatment of advanced gastric cancer.
    Wils J
    Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A gastric cancer patient who underwent curative resection by angiotension-induced hypertension cancer chemotherapy].
    Hakuta Y; Kimura T; Ashizawa I; Sato S; Hara T; Nakazima K
    Gan No Rinsho; 1984 Jan; 30(1):66-9. PubMed ID: 6422102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
    Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP).
    Arbuck SG; Douglass HO; Nava HR; Silk YN; Baroni M; Rustum YM
    Adv Exp Med Biol; 1988; 244():285-93. PubMed ID: 3073662
    [No Abstract]   [Full Text] [Related]  

  • 38. Mitomycin therapy in gastric cancer.
    Schnall S; Macdonald JS
    Oncology; 1993 Apr; 50 Suppl 1():70-7. PubMed ID: 8483560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
    Haim N; Epelbaum R; Cohen Y; Robinson E
    Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial.
    Kim SY; Park HC; Yoon C; Yoon HJ; Choi YM; Cho KS
    Cancer; 1998 Nov; 83(10):2054-9. PubMed ID: 9827708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.